Equities

SYNergy ScienTech Corp

6558:TAI

SYNergy ScienTech Corp

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (TWD)25.90
  • Today's Change0.20 / 0.78%
  • Shares traded8.46m
  • 1 Year change+1.97%
  • Beta--
Data delayed at least 20 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments7606371,063
Total Receivables, Net317294424
Total Inventory192307325
Prepaid expenses402523
Other current assets, total------
Total current assets1,3081,2621,835
Property, plant & equipment, net755818849
Goodwill, net------
Intangibles, net111718
Long term investments------
Note receivable - long term------
Other long term assets4.472222
Total assets2,1552,1882,755
LIABILITIES
Accounts payable15282144
Accrued expenses100133152
Notes payable/short-term debt439643
Current portion long-term debt/capital leases3286.556.51
Other current liabilities, total6218572
Total current liabilities684336918
Total long term debt0.24324269
Total debt371427319
Deferred income tax1.242.590.64
Minority interest------
Other liabilities, total0.741.550.07
Total liabilities6876641,187
SHAREHOLDERS EQUITY
Common stock938937940
Additional paid-in capital318316313
Retained earnings (accumulated deficit)270316375
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(57)(46)(59)
Total equity1,4691,5241,568
Total liabilities & shareholders' equity2,1552,1882,755
Total common shares outstanding949494
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.